Selenium Suppresses Lipopolysaccharide-Induced Fibrosis in Peritoneal Mesothelial Cells Through Inhibition of Epithelial-to-Mesenchymal Transition

Biological Trace Element Research

Volumn 161, Issue 2, 2014, Pages 202-209

  Liu, Jinyan ^a   Zeng, Lingling ^b   Zhao, Yuliang ^c   Zhu, Bin ^d   Ren, Wanjun ^d   Wu, Chunling ^d  

^a JINING NO 1 PEOPLE S HOSPITAL   (China)

^b Xinhua hospital of Chengdu   (China)

^c SICHUAN UNIVERSITY   (China)

^d SHANDONG UNIVERSITY   (China)

Author keywords

Epithelial to mesenchymal transition; Lipopolysaccharides; PI3K AKT; Reactive oxygen species; Selenium

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; FIBRONECTIN; GELATINASE B; LIPOPOLYSACCHARIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SODIUM SELENITE; UVOMORULIN; VIMENTIN; ACTIN; MMP9 PROTEIN, HUMAN; SELENIUM;

ARTICLE; CELL ACTIVATION; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FIBRIN FORMATION; INHIBITION KINETICS; MESOTHELIUM CELL; OXIDATIVE STRESS; PERITONEAL FIBROSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; BIOSYNTHESIS; CELL LINE; CHEMICALLY INDUCED; DRUG EFFECTS; HUMAN; METABOLISM; PATHOLOGY;

ACTINS; CELL LINE; COLLAGEN TYPE I; EPITHELIAL-MESENCHYMAL TRANSITION; FIBRONECTINS; HUMANS; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 9; PERITONEAL FIBROSIS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; SELENIUM; SIGNAL TRANSDUCTION; VIMENTIN;

EID: 84911002493     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-014-0091-8     Document Type: Article

References (43)

1. Zuo L, Wang M, Chinese Association of Blood Purification Management of Chinese Hospital Association (2010) Current burden and probable increasing incidence of ESRD in China. Clin Nephrol 74(Suppl 1):S20–S22
2. Modi GK, Jha V (2006) The incidence of end-stage renal disease in India: a population-based study. Kidney Int 70(12):2131–2133
3. Yang X, Yi C, Liu X et al (2013) Clinical outcome and risk factors for mortality in Chinese patients with diabetes on peritoneal dialysis: a 5-year clinical cohort study. Diabetes Res Clin Pract 100(3):354–361
4. Mehrotra R, Chiu YW, Kalantar-Zadeh K et al (2011) Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 171(2):110–118
5. Yeates K, Zhu N, Vonesh E et al (2012) Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant 27(9):3568–3575
6. Ueno T, Nakashima A, Doi S et al (2013) Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling. Kidney Int 84(2):297–307
7. Kitamoto M, Kato K, Sugimoto A et al (2011) Sairei-to ameliorates rat peritoneal fibrosis partly through suppression of oxidative stress. Nephron Exp Nephrol 117(3):e71–e81
8. de Lima SM, Otoni A, Sabino Ade P et al (2013) Inflammation, neoangiogenesis and fibrosis in peritoneal dialysis. Clin Chim Acta 421:46–50
9. Margetts PJ, Kolb M, Yu L et al (2001) A chronic inflammatory infusion model of peritoneal dialysis in rats. Perit Dial Int 21:S368–S372
10. Borges FR, Silva MD, Córdova MM et al (2014) Anti-inflammatory action of hydroalcoholic extract, dichloromethane fraction and steroid α-spinasterol from Polygala sabulosa in LPS-induced peritonitis in mice. J Ethnopharmacol 151(1):144–150
11. Liu ZW, Zhu HT, Chen KL et al (2013) Selenium attenuates high glucose-induced ROS/TLR-4 involved apoptosis of rat cardiomyocyte. Biol Trace Elem Res 156(1–3):262–270
12. Yang SY, Zhang L, Miao KK et al (2013) Effects of selenium intervention on chronic fluorosis-induced renal cell apoptosis in rats. Biol Trace Elem Res 153(1–3):237–242
13. Cases J, Vacchina V, Napolitano A et al (2001) Selenium from selenium-rich Spirulina is less bioavailable than selenium from sodium selenite and selenomethionine in selenium-deficient rats. J Nutr 131(9):2343–2350
14. Babaknejad N, Sayehmiri F, Sayehmiri K et al (2014) The relationship between selenium levels and breast cancer: a systematic review and meta-analysis. Biol Trace Elem Res 159(1–3):1–7
15. Tarp U, Overvad K, Hansen JC et al (1985) Low selenium level in severe rheumatoid arthritis. Scand J Rheumatol 14(2):97–101
16. Loscalzo J (2014) Keshan disease, selenium deficiency, and the selenoproteome. N Engl J Med 370(18):1756–1760
17. Nazıroğlu M, Yıldız K, Tamtürk B et al (2012) Selenium and psoriasis. Biol Trace Elem Res 150(1–3):3–9
18. Senol N, Nazıroğlu M, Yürüker V (2014) N-Acetylcysteine and selenium modulate oxidative stress, antioxidant vitamin and cytokine values in traumatic brain injury-induced rats. Neurochem Res 39(4):685–692
19. Nazıroğlu M, Karaoğlu A, Orhan Aksoy A (2004) Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology 195:221–230
20. Ding M, Potter JJ, Liu X et al (2010) Selenium supplementation decreases hepatic fibrosis in mice after chronic carbon tetrachloride administration. Biol Trace Elem Res 133(1):83–97
21. Zhu X, Guo K, Lu Y (2011) Selenium effectively inhibits 1,2-dihydroxynaphthalene-induced apoptosis in human lens epithelial cells through activation of PI3-K/Akt pathway. Mol Vis 17:2019–2027
22. Yu H, Huang J, Wang S et al (2013) Overexpression of Smad7 suppressed ROS/MMP9-dependent collagen synthesis through regulation of heme oxygenase-1. Mol Biol Rep 40(9):5307–5314
23. Tobar N, Villar V, Santibanez JF (2010) ROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion. Mol Cell Biochem 340(1–2):195–202
24. Boca M, D’Amato L, Distefano G et al (2007) Polycystin-1 induces cell migration by regulating phosphatidylinositol 3-kinase-dependent cytoskeletal rearrangements and GSK3beta-dependent cell cell mechanical adhesion. Mol Biol Cell 18:4050–4061
25. Tiwari N, Gheldof A, Tatari M et al (2012) EMT as the ultimate survival mechanism of cancer cells. Semin Cancer Biol 22(3):194–207
26. Aroeira LS, Aguilera A, Sánchez-Tomero JA et al (2007) Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 18(7):2004–2013
27. Zhou Q, Yang M, Lan H et al (2013) miR-30a negatively regulates TGF-β1-induced epithelial-mesenchymal transition and peritoneal fibrosis by targeting Snai1. Am J Pathol 183(3):808–819
28. Yokoi H, Kasahara M, Mori K et al (2012) Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis. Kidney Int 81(2):160–169
29. Gangji AS, Brimble KS, Margetts PJ (2009) Association between markers of inflammation, fibrosis and hypervolemia in peritoneal dialysis patients. Blood Purif 28(4):354–358
30. Zhao L, Yang R, Cheng L et al (2011) LPS-induced epithelial-mesenchymal transition of intrahepatic biliary epithelial cells. J Surg Res 171(2):819–825
31. Lee HB, Ha H (2007) Mechanisms of epithelial-mesenchymal transition of peritoneal mesothelial cells during peritoneal dialysis. J Korean Med Sci 22(6):943–945
32. Yu MA, Shin KS, Kim JH et al (2009) HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium. J Am Soc Nephrol 20(3):567–581
33. Copeland JW, Beaumont BW, Merrilees MJ et al (2007) Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone. Transplantation 83(6):809–814
34. Fusshoeller A (2008) Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis. Pediatr Nephrol 23(1):19–25
35. Duan SB, Liu GL, Wang YH et al (2012) Epithelial-to-mesenchymal transdifferentiation of renal tubular epithelial cell mediated by oxidative stress and intervention effect of probucol in diabetic nephropathy rats. Ren Fail 34(10):1244–1251
36. Baker RD, Baker SS, LaRosa K et al (1993) Selenium regulation of glutathione peroxidase in human hepatoma cell line Hep3B. Arch Biochem Biophys 304(1):53–57
37. Lothrop AP, Snider GW, Ruggles EL et al (2014) Why is mammalian thioredoxin reductase 1 so dependent upon the use of selenium? Biochemistry 53(3):554–565
38. Saito Y, Yoshida Y, Akazawa T et al (2003) Cell death caused by selenium deficiency and protective effect of antioxidants. J Biol Chem 278(41):39428–39434
39. Uğuz AC, Nazıroğlu M (2012) Effects of selenium on calcium signaling and apoptosis in rat dorsal root ganglion neurons induced by oxidative stress. Neurochem Res 37(8):1631–1638
40. Uğuz AC, Naziroğlu M, Espino J et al (2009) Selenium modulates oxidative stress-induced cell apoptosis in human myeloid HL-60 cells through regulation of calcium release and caspase-3 and -9 activities. J Membr Biol 232(1–3):15–23
41. Vunta H, Davis F, Palempalli UD et al (2007) The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages. J Biol Chem 282(25):17964–17973
42. Zhang W, Zhang R, Wang T et al (2014) Selenium inhibits LPS-induced pro-inflammatory gene expression by modulating MAPK and NF-κB signaling pathways in mouse mammary epithelial cells in primary culture. Inflammation 37(2):478–485
43. Zeng R, Yao Y, Han M et al (2008) Biliverdin reductase mediates hypoxia-induced EMT via PI3-kinase and Akt. J Am Soc Nephrol 19:380–387